Skip to content
StockMarketAgent
Direct answer
Salesforce is transitioning from a hyper-growth SaaS pioneer to a mature compounder. The thesis centers on a strategic shift from dilutive M&A to disciplined capital allocation, margin expansion, and robust free cash flow generation. Fair value range: low $172, high $303, with mid-point at $237.
Stock analysis

CRM Salesforce Inc. fair value $237–$303

CRM
By StockMarketAgent.AI team· supervised by
Analizado: 2026-05-09Próxima actualización: 2026-08-09Methodology v2.4Archetype: Mature compounderNYSE · Information Technology
View archive
Precio
$181.82
▲ +55.13 (+30.32%)
Valor razonable
$237
$237–$303
Calificación
Compra fuerte
confidence 88/100
Potencial alcista
+30.3%
upside to fair value
Margen de seguridad
$201.41
buy below · 15%
Capitalización bursátil
$148.7B
P/E fwd 12.2
Respaldo en inglésES
Mostrando la fuente en inglés mientras traducimos
Este informe aún no se ha traducido. Actualice en unos minutos una vez que la cola de traducción se ponga al día.

§1 Resumen ejecutivo

  • Transitioning to mature compounder focused on margin expansion and capital return.
  • Exceptional FCF supports aggressive share repurchases.
  • Market over-penalizing top-line fade; under-pricing cash economics.
  • Key risk is a return to undisciplined M&A or high SBC dilution.
Fair value
$237
Margin of safety
+23.3%
Confidence
88/100
Moat
9/10

Educational analysis only — not financial advice. Always do your own due diligence.

$181.82Price
FV $236.95
High $303.18

Salesforce is transitioning from a hyper-growth SaaS pioneer to a mature compounder. The thesis centers on a strategic shift from dilutive M&A to disciplined capital allocation, margin expansion, and robust free cash flow generation.

  • High switching costs within core
    High switching costs within core enterprise ecosystem
  • Deep integration of multi-cloud CRM
    Deep integration of multi-cloud CRM software
  • Cycle upside
    AI-driven product cycles reignite enterprise IT software spending.

§2 Caso bajista

A sustained macroeconomic downturn coupled with deep CRM saturation tests the model. If revenue growthRevenue growthYear-over-year change in revenue, expressed as a percentage. The starting point for any forward-earnings model and the lens through which scale, mix, and pricing power become visible. compresses below 5% and SBCStock-based compensationThe fair-value cost of equity awards (options, RSUs, performance shares) granted to employees. A real economic expense even though it is non-cash. remains elevated, true per-share value erodes despite optical cash generation.

Cómo puede fallar esta tesis

Growth Stagnation

20%· Medium

Core software markets saturate entirely, permanently capping top-line growth below 5%.

FV impact
-27%

M&A Relapse

15%· Low

Management abandons disciplined capital allocation, executing large dilutive acquisitions.

FV impact
-35%

AI Displacement

10%· Low

Agentforce fails to gain traction; nimble AI startups displace core service workflows.

FV impact
-20%
Señales de alerta temprana a vigilar
MétricaActualUmbral de activación
Revenue growth drops below 7% over two consecutive quarters.MonitorDeterioration versus the report thesis
Operating margins stall or compress below 30% target.MonitorDeterioration versus the report thesis
Share repurchases halted in favor of large-scale M&A.MonitorDeterioration versus the report thesis
Agentforce adoption rates disappoint internal targets.MonitorDeterioration versus the report thesis
SBC continues to consume outsized portion of operating cash flow.MonitorDeterioration versus the report thesis

§3 Historial financiero

Cuenta de resultados — últimos seis períodos
ConceptoT−0T−1T−2T−3T−4CAGR
Período2022-01-312023-01-312024-01-312025-01-312026-01-31Trend
Ingresos$26.49B$31.35B$34.86B$37.90B$41.53B+11.9%
Beneficio bruto$19.47B$22.99B$26.32B$29.25B$32.26B+13.5%
Beneficio operativo$548.0M$1.86B$6.00B$7.67B$8.92B+100.8%
Beneficio neto$1.44B$208.0M$4.14B$6.20B$7.46B+50.7%
BPA (diluido)$1.48$0.21$4.20$6.36$7.80+51.5%
EBITDA$3.85B$5.64B$9.96B$11.14B$12.55B+34.4%
I+D$4.47B$5.06B$4.91B$5.49B$5.99B+7.6%
SG&A$14.45B$16.08B$14.52B$15.19B$16.35B+3.1%

Puntuaciones de calidad

Piotroski F-score
7 / 9
Compuesto de calidad 0–9
Altman Z-score
2.49
Riesgo de quiebra (>3 seguro)
Beneish M-score
-2.66
Riesgo de manipulación de beneficios
OCF / Beneficio neto
2.01×
>1 indica alta calidad de los beneficios
Umbral de calidad contable
Pass
Umbral ajustado por sector
ROIC
9.2%
Rentabilidad del capital invertido
Sección 3

Numbers analysis

Asignación de capital

Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.

Suscriptores individuales — desde §411 secciones más

Leer el análisis completo — 11 secciones más.

Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.

Informe completo para cada ticker cubierto
24 meses de archivo de calificaciones
Briefings de lista de seguimiento + alertas de cambio de calificación
Exportación PDF + DOCX en cualquier idioma
Comenzar prueba gratuita
Cancela cuando quieras.
FAQ

CRM — frequently asked questions

  1. Based on our latest analysis, CRM looks meaningfully undervalued. The current price is $182 versus a composite fair-value midpoint of $237 (range $172–$303), which implies roughly 30.3% upside to the midpoint.
Related coverage

Names readers of CRM also follow

Same archetype: mature-compounder
Same sector: Information Technology